Skip to main content
DreamCIS INC. logo

DreamCIS INC. — Investor Relations & Filings

Ticker · 223250 ISIN · KR7223250002 KO Professional, scientific and technical activities
Open in API
Filings indexed 198 across all filing types
Latest filing 2025-08-14 AGM Information
Country KR South Korea
Listing KO 223250

About DreamCIS INC.

https://dreamcis.com/

DreamCIS INC. is a contract research organization (CRO) that provides comprehensive clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company's offerings cover the full lifecycle of clinical development, including project management, biostatistics, and data management for clinical trials and post-marketing surveillance. DreamCIS specializes in a wide range of therapeutic areas, with extensive experience in oncology, cardiovascular diseases, endocrinology, and rare diseases. In addition to full-service clinical development, the company also provides standalone services, dedicated support for medical device trials, and strategic consulting to guide clients through complex regulatory and development processes.

Recent filings

Filing Released Lang Actions
주주총회소집결의 (임시주주총회)
AGM Information Classification · 98% confidence The document is a formal notice of an Extraordinary General Meeting (EGM) for DreamCIS, detailing the date, location, and agenda items (such as articles of incorporation amendments and stock option grants). This type of document is a standard proxy solicitation or notice of meeting, which falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information to vote on upcoming corporate actions.
2025-08-14 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a short regulatory notice regarding the setting of a record date for a shareholder meeting (임시주주총회). It does not contain the full proxy materials or the meeting results themselves, but rather serves as a formal regulatory announcement of the record date. Given it is a standard regulatory disclosure regarding corporate governance procedures, it fits best under the general regulatory filing category.
2025-08-14 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'DreamCIS' covering the period from January 1, 2025, to June 30, 2025. It contains detailed financial information, corporate governance, business operations, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-08-13 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding the scheduling and details of an upcoming Investor Relations (IR) event (Corporate Presentation). It specifies the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation slides themselves, and it does not fit into the specific report categories, it is classified as a Regulatory Filing (RNS) as it serves as a standard corporate disclosure notice.
2025-06-11 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'DreamCIS INC.' (주식회사 드림씨아이에스) covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial information, corporate governance, business operations, and management discussions, which is characteristic of an interim/quarterly financial report. It is not a mere announcement or certification, but the full report itself. Q1 2025
2025-05-14 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean stock exchange (KIND) regarding a 'Correction Report' (정정신고) for a previously disclosed 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details changes to contract terms, specifically the contract amount and scope (number of clinical sites). Since this is a specific regulatory disclosure regarding a material contract change that does not fit into categories like M&A, dividends, or director dealings, it falls under the general regulatory filing category.
2025-05-09 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.